Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Clinical studies of incretin receptor agonists provide evidence of cardiovascular benefit, but they do not directly demonstrate anti-fibrotic effects, as fibrosis has not been measured as a primary outcome in major trials
top of page Tirzepatide Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
Each milliliter (mL) of this research preparation contains: To preserve chemical integrity and prevent degradation, the vial must be stored in a controlled environment between 2C and 8C (36F to 46F)
The published RCT data on bone density consequences is only beginning to emerge
launch in early January 2026
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
